12 | $OTLK Hod1.61 f23.655M | znewcar1 | 12/26/2024 12:36:06 PM |
11 | OTLK 21% v25,6M c1.79 f162M H1.85 morning pop got | znewcar1 | 02/04/2021 6:15:59 PM |
10 | OTLK 27% v28,8M c1.47 f127M H1.65 got S@1.35 | znewcar1 | 02/03/2021 5:35:16 PM |
9 | OTLK 20% v6,6M c1.050 f91,3M H1.09 | znewcar1 | 05/27/2020 4:59:40 PM |
8 | OTLK 48% v6,0M c.875 f38M late day BO over .65 | znewcar1 | 01/02/2020 7:46:38 PM |
7 | OTLK 53% v6,1M c1.59 f28,M H 1.74 After hour gap | znewcar1 | 12/03/2019 4:15:47 PM |
6 | OTLK 21% v1,3M c1.60 f28M H1.85 | znewcar1 | 08/28/2019 4:49:22 PM |
5 | OTLK 34% v28K c2.63 f22M H 2.89 gapup@2.2 S@2.1 | znewcar1 | 07/18/2019 9:20:06 PM |
4 | OTLK 20% v4,3M c2.32 f22M morning rocket with a a | znewcar1 | 06/14/2019 4:33:17 PM |
3 | OTLK 42% v25,5M c2.79 f22M H 2.89 gap up hit 2.6 | znewcar1 | 05/24/2019 4:09:43 PM |
2 | OTLK 42% v52M c3.00 f22M Another gap and | znewcar1 | 05/20/2019 11:33:10 PM |
1 | 24.27% v2,333,163 c1.2800 f85,091,062 morning | znewcar1 | 02/14/2019 4:31:13 PM |
Recent Articles
- Join the Fight: Innovative Industrial Properties Class Action
- Important Updates for Kyverna Therapeutics Investors Ahead
- DJM Capital Transitions Bella Terra Ownership to PGIM Real Estate
- Exiger Reports Forced Labor Risks Impacting Key Industries
- Chevron and Hess Merger Moves Forward After FTC Approval
- Concerns Rise Over NCAA Settlement: Justice Department Weighs In
- Litecoin Experiences Notable Surge with Significant Gains
- Uniti Group Inc. Unveils $589 Million Fiber Network Financing
- Revolutionary Kidney Function Assessment Approved by FDA
- ThreeD Capital Inc. Successfully Completes Private Placement
- United Airlines' $1 Million Contribution to Inaugural Events
- Lawsuit Targets Automakers Over Discrimination and Harassment
- Automotive Hoses Market Expected to Equate to $21.8 Billion
- REACH LA Unveils Initiative for Wildfire Relief Efforts
- CTEK Warns: Winter Weather May Threaten Vehicle Battery Life
- AI Revolution in Healthcare: What to Expect by 2028
- MediBeacon's TGFR System: A Revolutionary Kidney Assessment Tool
- Advanced Bifurcation Systems Inc. Achieves Major Financing Win
- Dios Exploration Announces Leadership Changes and Gold Focus
- Mawson Infrastructure Group Welcomes New CFO William C. Regan
- Investors of Micron Technology, Inc. Urged to Act Now
- The Remarkable Growth of Live Nation Entertainment Stock Over 10 Years
- EZGO Technologies Ltd. Posts Robust Revenue Growth in 2024
- Bank of America Employees to Receive Stock Awards for Success
- Revamping the DFC: Trump's Vision for Economic Power
- OpenAI Set to Launch Powerful o3 Mini AI Model Soon
- DATROWAY® Receives U.S. Approval for Advanced Breast Cancer Treatment
- Alliant Energy Corporation's Q4 and Year-End Earnings Call Insights
- Sensient Technologies Sets Cash Dividend for Shareholders
- Breakthrough Approval of DATROWAY for Advanced Breast Cancer
- ManaMed® Unveils Three Revolutionary Products for Patients
- Kimbell Royalty Partners Finalizes Strategic $230 Million Purchase
- Starbucks Announces Job Cuts in Strategy for Improved Efficiency
- Wildfires in Los Angeles Cause Significant Housing Damage
- Lifecore Biomedical Plans Special Meeting for Stockholders
- Alliant Energy Corporation Announces Dividend Payment News
- Convergent Energy and Power Secures Major Funding for Solar Advancements
- Granite REIT Announces January 2025 Distribution Details
- RiverNorth Funds Declare Preferred Dividends: A New Investment Opportunity
- Transforming $100 Into Wealth: A Decade with META Stocks
- Trump's Inaugural Celebration Full of Excitement and Promises
- Legal Insights on FTAI Aviation Ltd.'s Current Challenges
- Cometa Energía and Tierra Mojada Launch Cash Tender Offers
- US Government Invests $590 Million in Moderna's Vaccine Initiative
- Implications of LADWP's Fire Risks and Equipment Liability
- Hyperbridge Token Offering Extended to February 2025
- Empowering Minority Businesses: MBDA's Innovative Strategies
- Mawson Infrastructure Boosts Leadership with CFO Appointment
- Iovance Biotherapeutics Announces New Stock Options for Employees
- XORTX Therapeutics Transitions to New Auditor for Growth